Does TOFACITINIB Cause Hypersomnia? 132 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 132 reports of Hypersomnia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
132
Reports of Hypersomnia with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
20
Hospitalizations
How Dangerous Is Hypersomnia From TOFACITINIB?
Of the 132 reports, 1 (0.8%) resulted in death, 20 (15.2%) required hospitalization.
Is Hypersomnia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 132 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Hypersomnia?
PIMAVANSERIN (602)
ADALIMUMAB (467)
LENALIDOMIDE (401)
QUETIAPINE (394)
PREGABALIN (347)
TREPROSTINIL (317)
RISPERIDONE (302)
ARIPIPRAZOLE (286)
DULOXETINE (285)
OXYCODONE (280)
Which TOFACITINIB Alternatives Have Lower Hypersomnia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN